Authors:
JOSHI US
DERGHAM ST
CHEN YQ
DUGAN MC
CRISSMAN JD
VAITKEVICIUS VK
SARKAR FH
Citation: Us. Joshi et al., INHIBITION OF PANCREATIC TUMOR-CELL GROWTH IN CULTURE BY P21(WAF1) RECOMBINANT ADENOVIRUS, Pancreas, 16(2), 1998, pp. 107-113
Authors:
MOHAMMAD RM
DUGAN MC
MOHAMED AN
ALMATCHY VP
FLAKE TM
DERGHAM ST
SHIELDS AF
ALKATIB AA
VAITKEVICIUS VK
SARKAR FH
Citation: Rm. Mohammad et al., ESTABLISHMENT OF A HUMAN PANCREATIC TUMOR XENOGRAFT MODEL - POTENTIALAPPLICATION FOR PRECLINICAL EVALUATION OF NOVEL THERAPEUTIC AGENTS, Pancreas, 16(1), 1998, pp. 19-25
Authors:
DUGAN MC
DERGHAM ST
KUCWAY R
SINGH K
BIERNAT L
DU W
VAITKEVICIUS VK
CRISSMAN JD
SARKAR FH
Citation: Mc. Dugan et al., HER-2 NEU EXPRESSION IN PANCREATIC ADENOCARCINOMA - RELATION TO TUMORDIFFERENTIATION AND SURVIVAL/, Pancreas, 14(3), 1997, pp. 229-236
Authors:
DERGHAM ST
DUGAN MC
ARLAUSKAS P
DU W
VAITKEVICIUS VK
CRISSMAN JD
SARKAR FH
Citation: St. Dergham et al., RELATIONSHIP OF FAMILY CANCER HISTORY TO THE EXPRESSION OF P53, P21(WAF-1), HER-2 NEU, AND K-RAS MUTATION IN PANCREATIC ADENOCARCINOMA/, International journal of pancreatology, 21(3), 1997, pp. 225-234
Authors:
DERGHAM ST
DUGAN MC
KUCWAY R
DU W
KAMARAUSKIENE DS
VAITKEVICIUS VK
CRISSMAN JD
SARKAR FH
Citation: St. Dergham et al., PREVALENCE AND CLINICAL-SIGNIFICANCE OF COMBINED K-RAS MUTATION AND P53 ABERRATION IN PANCREATIC ADENOCARCINOMA, International journal of pancreatology, 21(2), 1997, pp. 127-143
Authors:
DERGHAM ST
DUGAN MC
JOSHI US
CHEN YC
DU W
SMITH DW
ARLAUSKAS P
CRISSMAN JD
VAITKEVICIUS VK
SARKAR FH
Citation: St. Dergham et al., THE CLINICAL-SIGNIFICANCE OF P21(WAF1 CIP-1) AND P53 EXPRESSION IN PANCREATIC ADENOCARCINOMA/, Cancer, 80(3), 1997, pp. 372-381
Authors:
MOHAMMAD RM
MOHAMED AN
HAMDAN MY
VO T
CHEN B
KATATO K
ABUBAKR YA
DUGAN MC
ALKATIB A
Citation: Rm. Mohammad et al., ESTABLISHMENT OF A HUMAN B-CLL XENOGRAFT MODEL - UTILITY AS A PRECLINICAL THERAPEUTIC MODEL, Leukemia, 10(1), 1996, pp. 130-137
Authors:
DUGAN MC
DERGHAM ST
KUCWAY R
VAITKEVICIUS VK
CRISSMAN JD
SARKAR FH
Citation: Mc. Dugan et al., MOLECULAR CLUES TO A NEW INTERPRETATION OF IN-SITU NEOPLASIA IN PANCREAS, Laboratory investigation, 74(1), 1996, pp. 781-781
Authors:
SAVASAN S
MOHAMED AN
LUCAS DR
DUGAN MC
RYAN JR
RAVINDRANATH Y
Citation: S. Savasan et al., ACUTE MYELOID-LEUKEMIA WITH T(8-16)(P11-P13) IN A CHILD AFTER INTRAUTERINE X-RAY-EXPOSURE, British Journal of Haematology, 94(4), 1996, pp. 702-704
Authors:
MOHAMMAD RM
DUGAN MC
VARTERASIAN M
PETTIT GR
ALKATIB A
Citation: Rm. Mohammad et al., PRECLINICAL EVALUATION OF BRYOSTATIN-1, DOLASTATIN BRYOSTATIN-10 AND THEIR COMBINATION AGAINST DIFFUSE LARGE-CELL LYMPHOMA XENOGRAFT, Blood, 88(10), 1996, pp. 3497-3497
Authors:
KATATO K
MOHAMMAD RM
DUGAN MC
SALEH M
AHMAD I
ALMATCHY VP
VARTERASIAN ML
ALKATIB A
Citation: K. Katato et al., SEQUENTIAL TREATMENT OF CHRONIC LYMPHOCYTIC-LEUKEMIA (CLL) WITH BRYOSTATIN-I AND 2-CHLORODEOXYADENOSINE - A PRECLINICAL STUDY, Blood, 88(10), 1996, pp. 2349-2349
Citation: Mc. Dugan, PRIMARY ADRENAL LEIOMYOSARCOMA IN ACQUIRED-IMMUNODEFICIENCY-SYNDROME, Archives of pathology and laboratory medicine, 120(9), 1996, pp. 797-798